Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
Apr 2008 - Am. J. Hematol.; 83(4):1096-8652 [PMID:18081032]
[Kitawaki T] [Kadowaki N] [Kondo T] [Ishikawa T] [Ichinohe T] [Teramukai S] [Fukushima M] [Kasai Y] [Maekawa T] [Uchiyama T]

Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2.
Sep 2003 - Melanoma Res.; 13(5):0960-8931 [PMID:14512794]
[Nagayama H] [Sato K] [Morishita M] [Uchimaru K] [Oyaizu N] [Inazawa T] [Yamasaki T] [Enomoto M] [Nakaoka T] [Nakamura T] [Maekawa T] [Yamamoto A] [Shimada S] [Saida T] [Kawakami Y] [Asano S] [Tani K] [Takahashi TA] [Yamashita N]